Transition From Temporary to Durable Circulatory Support Systems

J Am Coll Cardiol. 2020 Dec 22;76(25):2956-2964. doi: 10.1016/j.jacc.2020.10.036.

Abstract

Background: The decision to implant durable mechanical circulatory systems (MCSs) in patients on extracorporeal life support (ECLS) is challenging due to expected poor outcomes in these patients.

Objectives: The aim of this study was to identify outcome predictors that may facilitate future patient selection and decision making.

Methods: The Durable MCS after ECLS registry is a multicenter retrospective study that gathered data on consecutive patients who underwent MCS implantation after ECLS between January 2010 and August 2018 in 11 high-volume European centers. Several perioperative parameters were collected. The primary endpoint was survival at 1 year after durable MCS implantation.

Results: A total of 531 durable MCSs after ECLS were implanted during this period. The average patient age was 53 ± 12 years old. ECLS cannulation was peripheral in 87% of patients and 33% of the patients had history of cardiopulmonary resuscitation before ECLS implantation. The 30-day, 1-year, and 3-year actuarial survival rates were 77%, 53%, and 43%, respectively. The following predictors for 1-year outcome have been observed: age, female sex, lactate value, Model of End-Stage Liver Disease XI score, history of atrial fibrillation, redo surgery, and body mass index >30 kg/m2. On the basis of this data, a risk score and an app to estimate 1-year mortality was created.

Conclusions: The outcome in patients receiving durable MCS after ECLS remains limited, yet preoperative factors may allow differentiating futile patients from those with significant survival benefit.

Keywords: extracorporeal life support; extracorporeal membrane oxygenation; mechanical circulatory support; outcome; predictors.

Publication types

  • Multicenter Study

MeSH terms

  • Cardiopulmonary Resuscitation / methods
  • Clinical Decision-Making / methods
  • Europe / epidemiology
  • Extracorporeal Membrane Oxygenation* / instrumentation
  • Extracorporeal Membrane Oxygenation* / methods
  • Extracorporeal Membrane Oxygenation* / statistics & numerical data
  • Female
  • Heart-Assist Devices / statistics & numerical data*
  • Humans
  • Male
  • Middle Aged
  • Mortality
  • Patient Selection
  • Prognosis
  • Registries / statistics & numerical data
  • Retrospective Studies
  • Risk Factors
  • Shock, Cardiogenic / physiopathology
  • Shock, Cardiogenic / therapy
  • Survival Rate